Factors Associated with an Individual's Decision to Withdraw from Genetic Testing for Breast And Ovarian Cancer Susceptibility: Implications for Counseling-Reference-Cited by-同舟云学术

Factors Associated with an Individual's Decision to Withdraw from Genetic Testing for Breast And Ovarian Cancer Susceptibility: Implications for Counseling

Published:2007-04 Issue:1 Volume:11 Page:45-54
ISSN:1090-6576
Container-title:Genetic Testing
language:en
Short-container-title:Genetic Testing

Author:

Godard Béatrice¹,Pratte Annabelle¹,Dumont Martine²,Simard-Lebrun Adèle²,Simard Jacques²

Affiliation:

1. Department of Preventive and Social Medicine, Bioethics Programs, University of Montreal, Montreal, Quebec, Canada.

2. Cancer Genomics Laboratory, Oncology and Molecular Endocrinology Research Center, CHUQ Research Center and Laval University, Quebec, Canada.

Publisher

Mary Ann Liebert Inc

Subject

Genetics (clinical)

Link

http://www.liebertpub.com/doi/pdf/10.1089/gte.2006.9998

Reference48 articles.

1. Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

2. Life insurance and breast cancer risk assessment: Adverse selection, genetic testing decisions, and discrimination

3. Hormone Replacement Therapy and Life Expectancy After Prophylactic Oophorectomy in Women With BRCA1/2 Mutations: A Decision Analysis

4. Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want?

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The ENGAGE study: a 3-arm randomized hybrid type 1 effectiveness and implementation study of an in-home, collaborative PCP model of remote telegenetic services to increase uptake of cancer genetic services in childhood cancer survivors;BMC Health Services Research;2024-02-28

2. Identifying the Key Features of an Effective Non-Discrimination Policy: A Delphi Study;2024

3. Patient perspectives on risk-reducing salpingectomy with delayed oophorectomy for ovarian cancer risk-reduction: A systematic review of the literature;Gynecologic Oncology;2023-06

4. Comparing telemedicine and in-person gastrointestinal cancer genetic appointment outcomes during the COVID-19 pandemic;Hereditary Cancer in Clinical Practice;2023-05-08

5. Subjective valuation of Iranian women for screening for gene-related diseases: a case of breast cancer;BMC Public Health;2023-04-11